Clinical Trial

An Investigational Study Examining the Efficacy of QbMobile in Treatment Monitoring in Individuals With ADHD

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The current study will investigate if QbMobile can be used to improve the accuracy and objective identification of reduced ADHD symptoms in tests scores once treatment has been initiated.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-10-15; most recent amendment 2026-05-04.
Trial Details
NCT Number NCT07217977
Lead Sponsor Qbtech AB
Conditions Attention Deficit Disorder With Hyperactivity (ADHD), Attention Deficit Disorder (ADD)
Enrollment 175 participants
Start Date 2025-01-15
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-06